Form 4: Black Diamond Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Ali Behbahani, a Director of Black Diamond Therapeutics, Inc., received 7,707 shares of common stock on September 18, 2026.
Summary
- Grant/award: acquired 7,707 Common Stock at $1.93 ($14,875) on September 18, 2026; holds 110,236 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ali Behbahani — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-18 | Grant/award | Common Stock | 7,707 | $2 | $14.9K | 110,236 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-18 | Grant/award (7,707 shares) |
Keywords
insider transaction, Form 4, BDTX, Black Diamond Therapeutics, Inc., neutral, Ali Behbahani
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.